Imaging AI

Neusoft Medical Systems Co., Ltd. is a global medical imaging equipment manufacturer headquartered in Shenyang, China, specializing in diagnostic imaging systems for hospital and clinical settings. The company designs, manufactures, and distributes a comprehensive portfolio of medical imaging equipment including CT scanners (including photon-counting CT technology), MRI systems, digital subtraction angiography (DSA) systems, X-ray systems, PET/CT systems, and ultrasound systems. Recent product launches include China's first photon-counting CT scanner with NMPA approval, representing advancement in imaging resolution and reduced radiation dose. Neusoft Medical operates globally across multiple regions including Europe, Middle East, North Africa, Latin America, and Central Asia, with a focus on affordable, accessible healthcare technology. The company provides comprehensive services including global customer support, equipment servicing, advanced medical technology training through dedicated training centers, and operates imaging diagnostic centers. The company also offers MDaaS (Medical Device as a Service) solutions for flexible healthcare delivery models. Founded in 2003, Neusoft Medical maintains regulatory approvals for international markets and participates actively in major medical equipment conferences including European Congress of Radiology (ECR), China International Medical Equipment Fair (CMEF), and Arab Health. The organization emphasizes clinical performance optimization and patient outcome improvement through innovation in imaging technology and intelligent ecosystem development.

AGFA HealthCare is a global leader in enterprise imaging and diagnostic imaging software solutions serving healthcare organizations worldwide. The company develops and delivers an integrated Enterprise Imaging platform that consolidates PACS (Picture Archiving and Communication Systems), imaging analytics, and clinical workflows across multiple imaging modalities including radiology, cardiology, breast imaging, molecular imaging, digital pathology, POCUS (point-of-care ultrasound), teleradiology, medical photography, and specialty areas including dental, ophthalmology, and orthopedics. The Enterprise Imaging platform is engineered around clinician-first design principles, offering seamless workflow integration, blazing-fast streaming access, and specialty-tailored clinical workspaces. Key product components include: Streaming Client (web-based diagnostic access), XERO Universal Viewer (patient-centric cross-specialty imaging), Vendor Neutral Archive (VNA) for multimedia data consolidation, RUBEE AI (augmented intelligence ecosystem), RUBEE Orchestrator (workflow automation and orchestration), Business Intelligence tools, and Enterprise Imaging Scheduling. AGFA HealthCare delivers solutions across multiple deployment models: on-premises, cloud (SaaS), and hybrid architectures, utilizing cloud-native microservices. The platform is built with security-by-design principles, incorporating encryption, access control, auditing, and compliance frameworks. The company serves hospitals, health networks, and healthcare organizations of varying digital maturity and scale, from individual facilities to large enterprise systems. Services include hands-on onboarding, role-specific training programs, clinical coaching, customer experience center collaboration, CE credit programs, and 24/7 operational support. AGFA HealthCare has received recognition as "Best in KLAS" for 2026 across multiple enterprise imaging segments and maintains established partnerships and deployments globally.

Medical Metrics, Inc. (MMI) is an independent, full-service imaging core laboratory and clinical consulting firm specializing in centralized image analysis, endpoint strategy design, and regulatory support for clinical trials and medical device development. Founded 21+ years ago, MMI serves over 260 clients and partners globally, having supported 695+ clinical trials and contributed to more than 50 FDA regulatory approvals and clearances. The company operates a science-first approach with a multidisciplinary team of biomedical engineers, medical imaging specialists, and physician reviewers who design customized imaging methodologies and protocols for device sponsors, biopharmaceutical companies, and contract research organizations. Core services include imaging endpoint strategy and scientific consulting, image review charter development, clinical site management and training, image quality and compliance monitoring, expert centralized image analysis (via independent physician readers), data interpretation, publication strategy, and post-market surveillance. MMI maintains expertise across multiple therapeutic areas including spine (fusion, motion preservation, deformity correction), orthopedics (joint arthroplasty, biologics, cartilage repair), cardiovascular (peripheral vascular disease, atherectomy, stents), neurology (stroke, aneurysm, tumor), ENT, gastrointestinal and urology, oncology, and artificial intelligence research. The firm is ISO 13485 certified and operates with emphasis on accuracy, reliability, independence, and integrity in imaging outcomes assessment.

Syntermed, Inc. is a medical software company specializing in advanced diagnostic imaging analysis tools for nuclear cardiology, brain imaging, and PSMA PET/CT scanning. The company develops FDA-cleared, ISO 13485-certified software solutions that enhance clinical value and diagnostic accuracy across multiple imaging modalities. Primary product lines include the Cardiac Toolbox (eCTB), a comprehensive multi-modality platform for SPECT, PET, calcium scoring, myocardial blood flow, and strain analysis with integrated reporting and remote reading capabilities; NeuroQ 4, brain imaging analysis software for FDG-PET, Amyloid, SPECT, and DatScan imaging; and aPROMISE, a deep learning application for quantitative PSMA PET/CT assessment. Syntermed Live enables remote, cloud-based reading and reporting for nuclear cardiology studies. The company's Smart Scores technology provides automated quantitative segmental analysis with natural language report generation and physician decision support. Products are designed for nuclear medicine departments, cardiology practices, and neuroimaging centers. Syntermed has been the exclusive licensee of the Emory Cardiac Toolbox for over 25 years and recently acquired the intellectual property rights. The company maintains FDA Quality System Records and Pre-Market Notification (510(k)) clearance, along with European Union CE Mark (ISO 13485:2016) certification. All medical devices comply with applicable regulatory frameworks for diagnostic imaging software in the United States and European markets.

Thinking Systems Corp. is a medical imaging software company specializing in PACSCloud®, an AI-powered cloud-based Picture Archiving and Communication System (PACS). The platform serves oncology, cardiology, molecular imaging, and radiology practices of all sizes, from small centers to large nationwide networks. PACSCloud features advanced AI-driven analytics, HTML5-based viewers, and unlimited cloud scalability with stringent security protocols for storing, retrieving, and distributing medical images. The system supports multiple imaging modalities including PET-CT, SPECT-CT, PET-MR, CT, MR, CR/DR, ultrasound, and nuclear cardiology/echocardiography. Key capabilities include on-the-fly image fusion for hybrid studies, vendor-neutral archive (VNA) functionality with 100% data fidelity preservation, and seamless EMR integration enabling clinicians to view images directly from patient charts. PACSCloud's Virtual Image Exchange (VIE) technology allows secure image sharing without requiring software installation at source or destination endpoints. The platform integrates with third-party PACS systems and supports enterprise single sign-on via Okta or Active Directory. Trusted by major healthcare organizations including Florida Cancer Specialists and University of Miami Health System since 2012. The company emphasizes rapid performance, data integrity, comprehensive diagnostic tools customizable to institutional workflows, and world-class customer support.

Blackford Analysis is a UK-based healthcare technology company specializing in enterprise AI orchestration platforms for medical imaging and radiology. Founded in 2010 and headquartered in Edinburgh, the company enables hospitals, imaging centers, and radiology groups to deploy and manage multiple FDA/CE-approved AI applications through a single integrated platform. Blackford's solution integrates seamlessly into existing PACS and imaging informatics workflows, supporting 130+ contracted AI applications from 50+ vendor partners across 8 clinical service lines (Body, Breast, Cardiology, MSK, Neurology, Operational, Pediatric, Thoracic). The platform provides regulatory-compliant AI management with enhanced diagnostic confidence, operational efficiency, and ROI measurement. Deployed in over 1,000 hospitals and imaging centers primarily across North America and Australasia. Acquired by Bayer in January 2023.

Bunkerhill Health is an AI-enabled healthcare platform that facilitates the development, validation, regulatory approval, and deployment of artificial intelligence algorithms in clinical settings. Founded in 2019 and based in San Francisco, the company connects academic medical researchers with healthcare systems to accelerate the translation of AI innovations from research to clinical practice. The platform leverages generative AI and large language/vision models to provide clinical reasoning and automated action across the entire health system. It integrates electronic health record (EHR) data and employs FDA-cleared algorithms to analyze patient information, identify clinical risks, group patients for targeted interventions, and automate complex workflows including prior authorization, clinical trial matching, preventive care coordination, radiology finding follow-up, cancer registry submission, and care documentation. Key applications span cardiovascular care, cancer screening, critical care, preventive care, and operational efficiency. Bunkerhill's Carebricks platform enables healthcare systems to design and deploy custom AI-powered workflows for any clinical or operational domain without requiring extensive development cycles. The company has established partnerships with leading health systems including UCSF, Mayo Clinic, Georgetown/MedStar, and UTMB Health, and is supported by prominent investors including Sequoia Capital, Optum Ventures, Y Combinator, and others.

Level 42 AI is a Silicon Valley-based digital health startup developing software-defined hardware and AI algorithms that capture and analyze multi-modal vibrational biosignatures from the human body to predict, detect, diagnose, and monitor health conditions. The company's Vibrome® biosignature platform analyzes infrasonic-to-ultrasonic vibrational data from the heart, lungs, and gut—traditionally unobserved signals—using proprietary machine learning to identify early disease markers and quantify health state from brief 5–30 second data snippets. Level 42 AI offers three product categories: Point-of-Care systems for urgent care and telemedicine triage; Point-of-Habitat integrated biometric furniture for continuous home monitoring; and Point-of-Person wearables (watches, earrings, bracelets, necklaces, shoes) for self-directed continuous health phenotyping. The company is conducting clinical validation studies with Johns Hopkins School of Medicine and UCSF for COVID-19 biosignatures, with applications spanning respiratory (asthma, COPD, cystic fibrosis, TB), cardiovascular (coronary artery disease, heart failure, carotid disease), and other chronic conditions. Services include non-invasive sensor fusion data capture, online patient health tracking, practice management software, and just-in-time wellness insights.

Aclarion, Inc. is a healthcare technology company specializing in noninvasive diagnostic software for chronic low back and neck pain management. The company develops the NOCISCAN platform, a SaaS solution that leverages magnetic resonance spectroscopy (MRS) to analyze pain biomarkers in lumbar discs and distinguish between painful and nonpainful vertebral segments. NOCISCAN complements conventional lumbar MRI imaging by providing objective, patient-specific pain biomarker data without requiring invasive provocative discography. The platform generates individualized NOCI+/NOCI- scores for each disc, enabling clinicians to personalize treatment and surgical planning. NOCISCAN integrates with existing high-field MRI systems and includes components such as the MRS Exam Protocol, AMBRA Healthcare integration, and NOCIWEB data transfer capabilities. The solution supports improved surgical outcomes by helping physicians identify the true source of discogenic pain and optimize candidate selection for interventional procedures including fusion and disc replacement.

Fortis Life Sciences is a strategic platform company based in Waltham, Massachusetts, founded in August 2020. It operates as a multi-subsidiary life sciences tools provider delivering specialized reagents, diagnostic components, and custom development services to biopharma, diagnostics, and research organizations globally. The company integrates five ISO 13485 certified and GMP-compliant North American manufacturing and R&D locations under its "Farm-to-Bench" system, spanning antibody discovery and production, viral vector manufacturing, nanoparticle synthesis, molecular biology reagents, and diagnostic component CDMO services. Core product portfolio includes premium monoclonal and recombinant antibodies (validated for ELISA, Western blot, IHC, flow cytometry, spatial biology), VHH domain libraries (AbNano platform), lateral flow immunoassay components, assay-grade enzymes and master mixes, diagnostic grade nanoparticles (gold, platinum, silica), and lentiviral and AAV vector production. The company also offers contract manufacturing, antibody development, spatial biology imaging services, and precision lyophilization for stable diagnostic products. It serves over 10,000 customers across biopharma, diagnostics OEMs, contract manufacturers, academic research, and applied technology sectors.

Tempus AI is a precision medicine platform that leverages artificial intelligence and multimodal data analytics to accelerate clinical decision-making and drug development. The company provides healthcare providers and researchers with AI-enabled diagnostic and research tools, including genomic sequencing (xT and xR IVD platforms), algorithmic models (such as PurIST for therapy selection), and clinical trial matching capabilities. Tempus integrates extensive molecular profiling with real-world clinical data to identify personalized therapeutic opportunities, support guideline-concordant care, and enable earlier disease diagnosis across oncology and other therapeutic areas. The platform serves academic medical centers, oncologists, pharmaceutical companies, and biotech firms, supporting precision medicine workflows from diagnosis through treatment optimization.

Spectral MD (trading as Spectral AI) is a Dallas-based medical device company specializing in predictive wound healing diagnostics. The company's flagship product, the DeepView® Wound Imaging System, combines multispectral imaging technology with proprietary artificial intelligence algorithms to provide rapid, noninvasive wound healing assessments. The system differentiates between damaged and healthy tissue, delivering immediate binary healing predictions and detailed healing maps on Day One of assessment. DeepView supports clinical decision-making across multiple wound types including burns, diabetic foot ulcers, and acute/chronic wounds. The technology has received FDA Breakthrough Device Designation. The company is publicly traded on NASDAQ (ticker: MDAI) and holds 12 U.S. patents and 14 foreign patents related to its multispectral imaging and predictive AI platform.

iCRco Inc. is a Goleta, California-based manufacturer with over 35 years of experience (founded 1990, incorporated 2004) specializing in advanced medical imaging solutions. The company designs and distributes a comprehensive portfolio including digital X-ray systems, computed radiography (CR) equipment, CT scanners (including cone-beam CT for dental and veterinary applications), and hybrid imaging platforms. iCRco's proprietary technologies include the True Flat Scan Path™ computed radiography system and the Claris XT PET/CBCT fusion platform for cardiac and neurological imaging. The company also provides practice management and image storage/viewing software (Clarity PACS), CT reading services, and diagnostic reporting. Products serve hospitals, dental practices, chiropractic clinics, veterinary facilities, and non-destructive testing industries. Known for low-cost ownership models and global support, iCRco has processed over 2 billion images worldwide and supports trade-in upgrade pathways from legacy CR to modern digital radiography (AirDR) systems.

Parable Health is a mobile, computer vision-powered asynchronous telemedicine platform specializing in chronic woundcare management. The platform enables clinicians to measure, monitor, and manage complex patient populations through automated volumetric measurements, quantitative and qualitative assessments, and comprehensive risk scoring. Parable integrates with EHR systems and clinical IT infrastructure to automate complex workflows, standardize care protocols, and scale clinical expertise across broader patient populations. The platform leverages machine learning on millions of comprehensive wound assessments to deliver actionable clinical insights and reduces human error and variability in documentation. Parable supports both post-acute and inpatient wound management, as well as ambulatory follow-up scenarios including plastic surgery, orthopedics, and dermatology. The platform operates on familiar mobile devices with store-and-forward telemedicine capabilities, enabling remote collaboration and reducing excessive labor, transportation, and supply costs.

Biokinemetrics is a healthcare technology company delivering hospital-grade digital X-ray imaging systems, software platforms, and teleradiology services to independent medical practices, urgent care facilities, chiropractors, and veterinary clinics. The company specializes in space-efficient diagnostic imaging solutions designed for small-to-medium practices, offering integrated hardware and software packages that streamline clinical workflows, reduce operational complexity, and enhance diagnostic accuracy. Core offerings include ChiroSight (chiropractic imaging), VetSight (veterinary imaging), MedSight (medical practice imaging), and TeleRad (remote radiology consultation services). Biokinemetrics focuses on delivering equipment integration, comprehensive reporting tools, medical imaging system upgrades, warranty support, and tele-radiology services that enable practitioners to diagnose faster, manage operations more efficiently, and improve patient outcomes without requiring enterprise-scale infrastructure.

HJY Smart Medical Device Co., Ltd. (HJY Forward Medical Investment) is a Taiwan-based medical device manufacturer specializing in minimally invasive endoscopic surgery solutions and AI-assisted surgical technologies. Established in 2019, the company develops and manufactures innovative endoscopic vision systems addressing unmet needs in neuro- and orthopedic surgery. HJY's product portfolio includes FDA-approved VisualNext® 2D endoscopic vision systems for diagnostic and surgical applications, next-generation 3D head-mounted display (HMD) technology for real-time surgical visualization, and the HJY-YESS posterior lumbar retractor system for spine surgery. The company operates subsidiaries across China and the USA, positioning itself as a leader in next-generation endoscopy medtech with a focus on AI-integrated surgical platforms. HJY combines hardware innovation with artificial intelligence to advance minimally invasive surgical techniques.

Noul Co., Ltd. is a South Korean biotechnology company founded in 2015, specializing in AI-powered in vitro diagnostics and remote diagnosis solutions for infectious and non-infectious diseases. The company's flagship miLab™ platform is an advanced digital diagnostic system that automates blood analysis, sample preparation, and AI-driven pathology interpretation. Noul's product portfolio addresses critical global healthcare challenges, focusing on malaria diagnosis, complete blood count (CBC) and cell morphology analysis, and early cervical cancer detection through AI-powered cytology. The company has established international partnerships and distribution agreements, with presence across multiple countries. Noul's technology delivers significant improvements in diagnostic accessibility, speed (>2x reduction in analysis time), and accuracy, with clinical validation demonstrating high sensitivity and specificity. The company is committed to scaling diagnostic innovation globally, with a vision to impact one billion lives by 2030 through timely, accessible diagnostics for resource-limited and developed healthcare settings.

International Medical Solutions (IMS) is a software and services company specializing in cloud-native medical imaging platforms for diagnostic and educational applications. IMS develops DICOM-compliant viewing solutions built on HTML5 and cloud infrastructure (Google Cloud, Microsoft Azure) that enable healthcare clinicians, radiologists, and researchers to securely view, annotate, and share medical imaging data remotely without local installation or infrastructure overhead. Core offerings include IMS CloudVue (native cloud-based DICOM viewer with real-time performance), IMS CloudSync (cloud storage and synchronization with intelligent caching for offline/online workflows), and IMS Learn (web-based educational platform for creating interactive quizzes and training sessions with full-resolution medical images). The company maintains FDA, Health Canada, and ISO compliance with emphasis on data security, disaster recovery, and business continuity. IMS partners with academic medical centers, health systems, and radiology organizations globally.

Mint Medical GmbH is a Heidelberg-based medical imaging software company specializing in advanced analytics and structured reporting solutions for diagnostic radiology, clinical trials, and imaging biomarker research. The company's flagship product, mint Lesion, is a computer-assisted diagnostic platform that converts CT, MRI, and PET imaging data into standardized, actionable insights. The software provides AI-augmented guided structured reporting, implements dynamic response criteria (RECIST 1.1, iRECIST, CHESON, TNM, PI-RADS, RANO) with automated compliance checks, supports collaborative multi-reader workflows, and enables advanced analytics including volumetrics, radiomics, and tumor growth rate analysis. mint Lesion generates FHIR-compliant, high-quality structured datasets suitable for clinical routine oncology departments, Phase I-III clinical trials, pharmaceutical companies, CROs, and real-world data research. The platform integrates with existing PACS and RIS systems and is now part of the Brainlab Snke OS ecosystem following acquisition in 2021.

inTRAvent Medical Partners LP is a medical device company specializing in intra-operative imaging and neuro-navigation systems for neurosurgical procedures. The company develops portable ultrasound-based navigation technology enhanced with artificial intelligence and trajectory guidance to improve safety and efficacy in neurosurgery. Their flagship product, SOLOPASS®, combines 2D and 3D ultrasound imaging with AI-driven guidance to provide real-time procedural localization and navigation at the bedside. Designed for neurosurgeons performing minimally invasive procedures, the technology enables enhanced visualization of anatomical structures and catheter placement guidance. The company is focused on translating advanced imaging and navigation capabilities into practical, user-friendly solutions for intraoperative use.

Xironetic is a healthcare technology company specializing in augmented reality (AR) and mixed reality solutions for surgical applications. The company's flagship product, IntraOpVSP™, is an FDA-cleared augmented reality visualization software that transforms patient imaging data into three-dimensional holograms displayed in AR headsets during surgery. This enables surgeons to visualize surgical plans and anatomical targets in real-time across general, neuro, orthopedic, and vascular surgical disciplines. IntraOpVSP integrates CT and MRI imaging data with intuitive voice commands and gesture-based interfaces, providing hands-up reference displays that enhance surgical precision and decision-making. The company collaborates with clinical institutions, including the David Grant Medical Center, for product development and validation in complex surgical trauma cases.

Augmedit is a medical software company specializing in augmented reality (AR) technology for surgical procedures, medical education, and patient engagement. The company transforms 2D medical imaging data (CT and MRI scans) into interactive 3D holographic models, primarily compatible with Microsoft HoloLens 2. Augmedit's platform enables surgeons and clinical teams to conduct pre-operative planning, intra-operative guidance, and patient education using patient-specific holograms. The core product portfolio includes Lumi (cloud-based DICOM-to-3D conversion for 3D labs and researchers), LumiNE Lite (neurosurgical planning with automatic anatomical segmentation), and LumiNE Elite (intra-operative visualization with precise hologram-to-patient registration). Applications span neurosurgery, cranio-maxillofacial surgery, and emerging use cases in other surgical specialties. The subscription-based software integrates seamlessly into clinical workflows, supporting improved surgical outcomes, cost savings, and enhanced patient-clinician communication. Future developments include web and mobile platform compatibility.

Moon Surgical is a French-American medical device company headquartered in San Carlos, California, specializing in AI-powered robotic assistance for minimally invasive surgery. The company develops the Maestro™ platform, a digital surgical assistant robot designed to enhance surgeon autonomy and efficiency during laparoscopic and soft tissue procedures. The platform features dual robotic arms for instrument manipulation and incorporates ScoPilot™, an FDA-cleared AI-enhanced intraoperative guidance tool powered by NVIDIA Holoscan. Maestro is compatible with multiple surgical specialties including abdominal, thoracic, urology, and gynecology procedures. The system has received FDA 510(k) clearance and CE marking, with commercial deployments at leading U.S. and European surgical centers including Lee Health and Surgeon's Point Surgery Center. Moon Surgical focuses on improving patient safety, streamlining operating room workflows, and making advanced robotic-assisted surgery accessible to a broad range of surgical teams while maintaining surgeon control and decision-making authority.

Sibel Health is an FDA-cleared digital health company specializing in wireless vital signs monitoring solutions for neonatal, maternal, adult, and remote care settings. The company's flagship ANNE® One platform delivers continuous, real-time vital signs tracking through wearable wireless sensors that integrate with mobile devices and clinical information systems. Sibel's technology enables proactive monitoring and data-driven clinical decision support across multiple care environments—including hospital-based clinical care, remote patient monitoring, hospital-at-home programs, and global health initiatives. The platform supports advanced applications in neonatal intensive care, maternal wellness tracking, personalized adult care interventions, and research/clinical trials. Sibel has deployed systems across 20+ countries and partners with leading organizations including Samsung and Maruho Co., Ltd. The company emphasizes engineering excellence, peer-reviewed validation, and accessibility for under-resourced healthcare settings.

IRM Inc. is a healthcare software solutions provider specializing in cloud-based enterprise data management and clinical decision support systems. The company develops PACS and imaging informatics platforms designed to streamline hospital and clinic workflows while enabling secure access to medical imaging data and AI-driven analytics. IRM's offerings focus on clinical efficiency, data orchestration, and collaborative research capabilities, allowing healthcare organizations to eliminate traditional hardware infrastructure while maintaining robust data security and compliance standards.

Siemens Healthineers AG is a global leader in medical technology specializing in diagnostic imaging, laboratory diagnostics, precision therapy, and advanced healthcare solutions. Founded in 1847 and spun off as an independent entity in 2015, the company employs approximately 74,000 people worldwide and invests over €1 billion annually in research and development. The company's portfolio encompasses advanced imaging technologies including PET-CT scanners, MRI systems, and wireless ultrasound transducers, alongside laboratory diagnostics platforms conducting over 9 billion tests annually. Siemens Healthineers is particularly renowned for precision therapy innovations in oncology, featuring image-guided treatments and radiation therapy solutions. The company operates in more than 70 countries, with solutions trusted by 90% of leading hospitals globally. Its AI-driven diagnostic software and digital tools optimize clinical workflows and support early disease detection, particularly for lung and prostate cancer screening. The company maintains strategic partnerships with major healthcare providers and research institutions to enhance innovation and patient outcomes.

Medis Medical Imaging Systems is a Netherlands-based software company founded in 1989 as a spin-off from Leiden University Medical Centre. Specializing in vendor-independent, AI-powered cardiovascular image analysis software, Medis develops solutions for quantitative analysis across multiple imaging modalities including X-ray, CT, MRI, ultrasound, and intravascular imaging (IVUS/OCT). The company's flagship products include Medis QFR® (coronary physiology analysis via deep learning), Medis Suite MR (cardiac MRI post-processing), Medis Suite CT (cardiovascular CT quantification), Medis Suite XA (coronary and ventricular X-ray analysis), Medis Suite Ultrasound (cardiac deformation analysis), and Intravascular (IVUS/OCT post-processing). With ~126 employees globally and operations across 27+ countries, Medis serves hospitals, imaging centers, and research institutions. The company holds multiple patents and certifications; Medis QFR® has Class I recommendations in the 2024 ESC Guidelines for chronic coronary syndrome management. Medis emphasizes scientific rigor, clinical workflow efficiency, and user-oriented design in supporting cardiologists, radiologists, and researchers.

AEYE Health is an FDA-cleared AI diagnostic platform specializing in autonomous diabetic retinopathy screening from retinal images. The company offers AEYE-DS, the only fully autonomous AI solution for point-of-care diabetic retinopathy detection requiring a single image per eye, enabling primary care physicians, pharmacies, and home care providers to perform rapid screening without specialist referral. AEYE Health also develops AEYE-X, a broader retinal imaging diagnostic platform for detecting multiple eye and systemic diseases. Operating with handheld cameras (Aurora AEYE with Optomed) and robotic tabletop systems (integrated with Topcon Healthcare), the company targets the >40 million Americans with diabetes, achieving 92-93% sensitivity and >99% image success rates. The solution is CPT 92229 reimbursable and addresses critical gaps in diabetic retinopathy care access.

Oncosoft is an AI-driven software company specializing in radiation oncology workflows. The company develops an end-to-end intelligent ecosystem that supports every step of radiotherapy planning, from patient imaging through treatment planning and chart close-out. Its flagship product, OncoStudio, uses clinical-grade AI for automatic organ segmentation (auto-contouring) and organ-at-risk delineation, reducing manual contouring time from hours to minutes. OncoFlow provides integrated workflow management to eliminate errors across the entire radiotherapy process. Products under development include OncoPlan for particle therapy optimization and OncoRPT for radiopharmaceutical therapy personalization. Oncosoft supports DICOM and HL7 FHIR standards, works with 190+ normal organs and clinical target volumes, and is expanding to 300+ structures by 2025. The platform currently operates on local institutional servers with cloud deployment planned for 2026. Backed by partnerships with major Korean hospitals and expanding into U.S. and Japanese markets.

NIRAMAI Health Analytix is an AI-powered medical device company specializing in thermal imaging-based breast cancer screening. Founded in 2016 and headquartered in Bangalore, India, the company develops non-invasive, radiation-free diagnostic solutions for early breast cancer detection. The core technology, Thermalytix, is a computer-aided diagnostic engine combining high-resolution thermal sensing with cloud-hosted machine learning analytics to analyze thermal images and detect breast abnormalities. The platform is clinically validated, backed by 39 patents and 55+ peer-reviewed publications, and has screened 300,000+ women across 200+ hospitals in 22+ countries. NIRAMAI's thermal imaging approach offers significant advantages: it is painless, contactless, privacy-preserving, and operates at 10-20% of the cost of traditional screening methods. The technology is accessible across age groups (18-80+) and is particularly suited for primary care clinics, remote communities, and outreach programs. NIRAMAI SMILE-100, the company's flagship system, received US FDA clearance and CE marking for European markets. The company has received numerous international awards including World Bank Global Women Health Award, National Startup Award, and recognition as a top 100 AI startup globally.

Cloudphysician is an AI-driven healthcare technology company providing AI-powered Smart-ICU solutions and virtual critical care services. Founded in 2017 by critical care physicians, the company operates the proprietary RADAR platform—an ambient intelligence system integrating high-definition video, computer vision, AI analytics, and electronic medical record data to enable 24/7 remote ICU monitoring and clinical decision support. The platform detects and prevents adverse events including inpatient falls, pressure ulcers, central line infections, and catheter-associated UTIs, reducing hospital-acquired complications and associated costs. Cloudphysician has deployed solutions across 280+ hospitals managing 2,000+ ICU beds across 22 Indian states, serving 130,000+ patients. The company offers disease-specific AI agents, real-time video analysis, virtual nursing capabilities, and Smart-ICU in a Box solutions optimized for both urban and rural healthcare settings. Its hardware-agnostic architecture integrates seamlessly with existing hospital infrastructure (monitors, cameras, tablets) without requiring device upgrades. The platform operates securely on-premise or in cloud environments with full HIPAA, SOC 2, and ISO 27001 compliance, ensuring patient data remains within hospital environments with no external data transfer.

Methapharm is a specialty pharmaceutical company focused on developing, acquiring, licensing, and promoting healthcare products across North America. Founded in 1996 and based in Coral Springs, Florida, with approximately 85 employees and $19.4 million in revenue, the company operates distribution facilities throughout the United States and Canada with full licensing to distribute prescription drugs. Methapharm specializes in respiratory diagnostics, imaging products, oncology, and neonatology therapeutics. The company's core competency lies in identifying and bringing specialty pharmaceutical products to market that address unmet medical needs in hospital and clinical settings. Key portfolio products include Provocholine (respiratory diagnostic), Aridol, and Tranexamic Acid Injection. Methapharm Respiratory, a dedicated division, has established a strong reputation in respiratory care diagnostics. The company partners strategically with international pharmaceutical manufacturers to distribute specialty products, positioning itself as a critical supply chain partner for healthcare systems requiring access to innovative and hard-to-source pharmaceutical solutions.

Applied Neuroscience develops advanced EEG (electroencephalography) analysis and neurofeedback software platforms for clinicians, researchers, and academic institutions. The company's flagship product, NeuroGuide™, is a comprehensive conventional and quantitative EEG (qEEG) system offering dynamic EEG databases, source localization analysis (swLORETA), coherence mapping, phase analysis, and 3D brain imaging capabilities. NeuroGuide enables real-time EEG visualization with dynamic color maps and automated clinical report generation. The platform supports Z-score neurofeedback protocols with surface, LORETA, and brain-computer interface training modes, including symptom-checklist-driven protocol preparation. NeuroNavigator™ adds current density Z-score mapping for precise functional brain network localization. Additional offerings include automatic clinical report writing integrated with Microsoft Office, expert clinical consultation services, and comprehensive training programs delivered through webinars and workshops. The company serves psychiatrists, neurologists, psychologists, neuropsychologists, and researchers across major universities including Drexel, Stanford, UC San Diego, and Swansea University. Products support conventional and quantitative EEG analysis with advanced metrics including phase locking, phase resetting, cross-frequency analysis, batch processing, and electrophysiological assessment tools.

Subtle Medical is an AI-powered medical imaging software company specializing in vendor-neutral deep learning solutions that enhance image quality and accelerate acquisition protocols across MRI and PET imaging systems. Founded in 2017 and based in Silicon Valley, the company develops software upgrades that improve existing diagnostic scanners without requiring new hardware investments. Their FDA-cleared product portfolio includes SubtleHD(MR)™ for MRI image quality enhancement and acceleration (enabling up to 80% faster sequences), SubtlePET™ for low-count PET denoising (reducing scan counts by up to 75%), SubtleSYNTH™ for synthetic imaging generation, and the integrated Subtle-ELITE™ suite combining multiple AI tools. With 9 FDA clearances, over 30 patents, and deployment on nearly 1,000 scanners globally, Subtle Medical partners with major imaging manufacturers and healthcare systems to improve workflow efficiency and diagnostic confidence while reducing patient scan times and radiation/contrast agent exposure.

QView Medical, Inc. is a Silicon Valley-based medical device company specializing in AI-driven diagnostic software for breast imaging. The company has over 30 years of expertise in computer-aided detection (CAD) and automated breast ultrasound (ABUS) systems. QView's flagship product, AI-QVCAD, is FDA-approved software designed for GEHC's automated breast ultrasound platform, enabling breast cancer screening in women with mammographically dense breast tissue. The technology provides single-glance exam review capability, significantly improving detection efficiency and clinical workflow. QView has achieved multiple FDA PMA (Premarket Approval) designations, including approvals for R2 mammography CAD, R2 lung CT CAD, U-Systems ABUS, and QVCAD, positioning the company as a leader in medical imaging AI and CAD software development.

Advanced Image Enhancement (AIE) develops proprietary image enhancement algorithms for diagnostic radiology. The company's software solutions improve the clarity and detail of radiological images to aid radiologists in screening and diagnosis of disease. AIE's technology is positioned as a complement to artificial intelligence applications in medical imaging, enhancing the visibility of subtle abnormalities that may be difficult to detect on standard images. The platform targets radiology departments and imaging centers seeking to optimize diagnostic accuracy and support radiologist decision-making in clinical workflows.

BrainScope is a commercial-stage medical neurotechnology company specializing in AI-powered EEG-based diagnostic solutions for brain health. Founded in 2006 and based in Rockville, Maryland, BrainScope has developed a proprietary platform that applies machine learning and computational neuroscience to transform brain electrical activity (EEG) into objective clinical biomarkers. The company created the first FDA-cleared AI/Machine Learning medical device in neurology and holds a portfolio of 83 issued patents. BrainScope's primary offering is a hand-held, point-of-care device for assessing mild traumatic brain injuries (mTBI), structural brain bleeds, and concussions in under 20 minutes. The technology has demonstrated ~50% reduction in unnecessary head CT scans and substantial reductions in emergency department patient length of stay. Beyond head injury assessment, BrainScope is developing novel biomarkers for stroke detection, early Alzheimer's detection (with dementia risk prediction up to 7 years before initial diagnosis), and other CNS indications. The company serves acute care settings, hospitals, emergency departments, and pharmaceutical/drug development partners.

Astute Imaging is a healthcare IT solutions company specializing in AI-powered cardiovascular imaging software for image-guided therapy and precision medicine. Founded in 2021 as a spin-off from Fivos Health, the company develops a cloud-based SaaS platform that integrates with EMR, PACS, and clinical registries. The platform automates surgery planning, device recommendations, vascular modeling and finite element analysis, and patient follow-up tracking. Astute Imaging serves healthcare providers and medical device manufacturers, supporting over 2,500 surgeons across 1,000+ centers. Key offerings include PEMS® (Patient Tracking and Management System), Preview® surgical planning tools, and proprietary finite element analysis for aortic disease management. The platform leverages 25 years of annotated vascular imaging data and AI to enhance diagnostic accuracy, provider productivity, and patient outcomes while reducing time-to-market for medical device development.

APQ Health develops FDA-cleared AI-powered software for automated quantitative analysis of 3D medical images, specializing in coronary plaque analysis from CT angiography. The company's flagship product, Autoplaque, provides deep learning–enabled quantification of coronary atherosclerosis, plaque characterization, and stenosis assessment. Backed by over 100 peer-reviewed publications and validation across 35 academic sites, including the landmark SCOT-HEART multicenter trial, Autoplaque demonstrates 95% agreement with invasive IVUS and ICC 0.95 correlation with expert readers. The software enables clinicians to quantify total plaque volume, identify low-attenuation (vulnerable) plaque burden, and predict patient-specific myocardial infarction risk. APQ Health's solution integrates clinical decision support with evidence-driven insights to improve cardiac risk stratification and patient outcomes.

Trivitron Healthcare is a Chennai-based private medical technology company established in 1997, operating across 180+ countries with 15 USFDA- and CE-certified manufacturing facilities. The company specializes in integrated healthcare solutions spanning medical imaging, in-vitro diagnostics (IVD), newborn screening, radiation protection, critical care equipment, renal care solutions, and operating room systems. Trivitron delivers comprehensive turnkey healthcare solutions including facility design, equipment procurement, installation, and ongoing maintenance support. The company operates modern laboratory platforms for high-throughput automated diagnostics, portable screening systems for early disease detection in resource-limited settings, patient monitoring and ventilation systems for ICU environments, and AI-enhanced imaging analytics. With over 100,000 customers including hospitals, clinics, and laboratories globally, Trivitron focuses on making quality healthcare accessible and affordable in underserved regions, particularly across Africa and developing economies.

CTCELLS is a precision oncology company specializing in advanced liquid biopsy diagnostics and innovative immunotherapy development. The company leverages proprietary Circulating Tumor Cell (CTC) isolation technology powered by automated microfluidic systems to enable comprehensive analysis of all CTC types. CTCELLS offers two integrated platforms: (1) CTCeptor, a diagnostic platform for total CTC isolation and characterization, complemented by HyPICC (Hydrogel Pellicle for Lossless Immunocytochemistry) technology achieving >97% cell retention for downstream analysis; and (2) therapeutic development programs including RACE (Receptor Antibody Conjugated Engager) bispecific antibodies and Membrane Bound Protein (MBP)-enhanced natural killer cell therapies. The company's integrated diagnostics-to-therapeutics model enables patient-tailored cancer treatment matching individual tumor characteristics with optimized therapeutic approaches.

Cycle Clarity is a healthcare technology company specializing in AI-driven clinical decision support for reproductive medicine. The company's flagship product, MyCycleClarity, combines Follicle Clarity—an FDA-cleared neural network—with cloud-based analytics to standardize and accelerate ovarian follicle measurements during fertility treatment monitoring. The platform integrates with electronic medical records to provide real-time follicle detection, measurement accuracy, and predictive analytics for optimal oocyte retrieval timing. Key benefits include reduced ultrasound scan times (from 15–20 minutes to 2–3 minutes per patient), standardized measurements across providers, improved clinical workflow efficiency, decreased patient discomfort, and better resource allocation in fertility clinics. HIPAA and SOC2 compliant. Serves leading fertility centers nationally.

PediaMetrix is a healthcare technology company specializing in AI and computer vision solutions for pediatric care. The company's flagship product, SoftSpot™, is the first and only FDA-cleared mobile application for point-of-care measurements of infant head deformity conditions, including positional plagiocephaly and other cranial abnormalities. SoftSpot enables both pediatric providers and parents to perform quantitative, repeatable head shape assessments using smartphone-based computer vision technology, supporting early detection and monitoring in clinical and home environments. The platform is designed for telemedicine and in-office use, with results interpreted by qualified healthcare professionals. PediaMetrix also offers Tummy Time Tools to support infant developmental activities. The company's mission is to make advanced measurement technology accessible to improve patient outcomes and reduce costs in pediatric healthcare delivery while maintaining robust data security through encryption systems.

MVision AI is a Helsinki-based developer of AI-powered software solutions for automating and standardizing radiotherapy treatment planning in cancer care. The company specializes in intelligent auto-segmentation platforms that reduce manual contouring time, improve consistency across clinical processes, and accelerate patient treatment preparation. Key offerings include Workspace+, a modular, secure platform integrating contouring, synthetic imaging, dose prediction, and contour propagation; and GBS™ (Guideline-Based Segmentation), which standardizes contours according to clinical guidelines while enabling clinician education. MVision AI's solutions are designed for seamless integration with existing treatment planning systems and have processed over 100,000 scans across European medical institutions including Turku University Hospital and North Estonia Medical Centre. The platform demonstrates up to 95% manual work time savings and 20% average improvement in contouring consistency.

IONIC Health is a health-tech company specializing in automation and integration technologies for diagnostic medicine and healthcare delivery. The company provides remote operations platforms, monitoring and management software, and AI-powered reporting solutions for imaging devices and clinical workflows. IONIC Health serves healthcare providers worldwide with solutions for teleradiology, equipment teleoperation, sensor data analytics, and structured medical report generation. The platform supports 300+ devices in remote teleoperation, monitors 50,000+ healthcare equipment units, and has processed over 1 million medical reports. The company also offers consulting services for digital transformation, process optimization, cost reduction (5-15%), and big data analytics in diagnostic medicine. With 90+ B2B clients including major healthcare networks, 110+ employees across 4 countries, and partnerships with leading diagnostic imaging centers, IONIC Health enables efficiency gains and expanded access to diagnostic services through cloud-based automation.

EnsoData is a healthcare technology company specializing in AI-powered software solutions for sleep medicine diagnostics and management. Founded in 2015 and based in Madison, Wisconsin, the company develops FDA-cleared cloud-based platforms that automate sleep study scoring and analysis using machine learning to process polysomnography (PSG) and home sleep apnea test (HSAT) waveforms. EnsoData's integrated ecosystem—comprising EnsoHST (multi-night home sleep testing device), EnsoSleep (AI-assisted scoring and analysis), EnsoHub (centralized study management platform), and Therapy Track (long-term therapy monitoring)—enables sleep clinics to streamline workflows, reduce diagnostic turnaround times, and improve clinical accuracy. The platform has processed over 2.8 million studies and impacted more than 2.5 million patients. EnsoData serves 500+ sleep clinics globally and achieves 97% patient success rates with >92% sensitivity for obstructive sleep apnea detection. The company's solutions address scalability challenges in sleep medicine and expand access to diagnosis for the estimated 425 million patients worldwide with undiagnosed sleep disorders.

Infervision is a global medical artificial intelligence company founded in 2015, specializing in deep learning technologies for medical imaging and clinical diagnostics. Headquartered in Beijing with a US office in Lyndhurst, New Jersey, Infervision develops AI-powered platforms designed for radiologists and clinicians to enhance diagnostic accuracy and clinical workflows. The company's InferRead™ suite processes over 33,000 exams daily and provides comprehensive imaging analysis across multiple organ systems including lungs, cardiovascular, breast, and bone. InferOperate™ offers surgical planning and intraoperative navigation, while InferScholar™ and InferMatrix™ platforms support medical research and innovation. Infervision's solutions assist in detecting conditions such as lung cancer, stroke, pneumonia, tuberculosis, and fractures from various imaging scans. The company holds regulatory approvals from the US FDA, China NMPA, EU CE, UK UKCA, and Japan PMDA, with products deployed across 1,000+ medical institutions in 30+ countries.

Imeka Solutions Inc. is a Canadian medical software company specializing in advanced brain imaging analysis and neuroinflammation assessment. Founded in 2011 as a spinoff from the University of Sherbrooke, the company develops AI-powered diffusion MRI analysis tools for clinical neurology and pharmaceutical research. ANDI (Advanced Neuro Diagnostic Imaging) is an FDA 510(k)-cleared medical device software that quantifies white matter microstructure, axonal integrity, and myelin health to support diagnostics and monitoring of neurodegenerative diseases including Alzheimer's disease, multiple sclerosis, Parkinson's disease, and traumatic brain injury. The platform automates DTI (Diffusion Tensor Imaging) processing and provides comprehensive clinical reports for neurologists and researchers. Imeka serves clinicians, academic medical centers, and pharmaceutical companies developing neurotherapeutics, with strategic partnerships across North America, Europe, and Asia.

Diagnocat is an FDA-cleared, AI-powered cloud-based platform for automated dental image analysis serving dentists, clinics, dental laboratories, and radiologists across 50+ countries. The platform analyzes 2D (intraoral X-rays, panoramic OPGs) and 3D (CBCT) dental images, detecting over 60 conditions in 3D and 40+ in 2D with high accuracy. Core capabilities include intelligent segmentation of dental structures, automatic STL model generation for lab workflows, and multi-format diagnostic reporting (radiological, implant, orthodontic, and analytics reports). Diagnocat integrates with leading practice management systems and HIPAA/SOC 2-compliant cloud infrastructure enables secure patient data storage and peer-to-peer case sharing. The platform streamlines clinical workflows through one-click report generation, supports patient education with visual reports, and offers specialized modules for endodontists, periodontists, orthodontists, oral surgeons, prosthodontists, and pediatric dentists. Founded in 2017, Diagnocat is developed with input from 55 leading dental professionals.

ECOTRON Co., Ltd. is a South Korean medical imaging equipment manufacturer specializing in X-ray systems and diagnostic imaging solutions. The company designs and manufactures a comprehensive portfolio of radiography systems, portable X-ray devices, surgical imaging systems, dental imaging equipment, and X-ray generators. ECOTRON also develops AI-based diagnostic solutions and specialized medical imaging devices for urology applications. The product range extends to veterinary X-ray systems and offers OEM/ODM manufacturing services for medical device partners. The company positions itself as a leader in advanced X-ray technology and sustainable medical solutions, with a commitment to innovation and customer support through exhibitions, technical inquiries, and comprehensive customer service channels.

Firefly Neuroscience is an FDA-cleared neurodiagnostic software platform company specializing in objective brain health assessment and early detection of neurological and psychiatric conditions. The company's flagship product, Evoke™ System, combines quantitative EEG (qEEG) and event-related potentials (ERP) analysis with proprietary AI and machine learning to translate complex brain signals into clinically actionable insights. Built on a proprietary database of over 191,000 EEG and ERP sessions from individuals aged 12–85, Evoke™ enables clinicians to identify deviations in brain function, differentiate overlapping conditions (depression, anxiety, ADHD, concussion, cognitive decline, neurodegenerative disorders), and track treatment response with precision. The platform delivers age-matched normative comparisons and cloud-based reporting to support earlier diagnosis, more targeted treatment planning, and personalized care protocols. Firefly serves healthcare practitioners seeking measurable, data-driven neurological assessment and supports CNS drug developers through biomarker development and companion diagnostic collaborations.

TeraRecon, Inc. is a healthcare software company specializing in AI-powered advanced medical imaging visualization and enterprise image management solutions. The company delivers SaaS-based platforms—TeraRecon AV (registered as Intuition globally) and TeraRecon DETECT—that combine advanced 3D visualization with AI-driven automation to enhance diagnostic precision and clinical workflow efficiency. Products support radiology, cardiology, neurology, vascular surgery, and oncology applications with features including medical image viewing, AI biomarker detection, real-time decision support, and enterprise imaging consolidation. Founded in 1997 and based in Durham, North Carolina, TeraRecon serves approximately 1,900 clinical sites globally with ~195-244 employees and ~$41M annual revenue. The platform emphasizes interoperability, enabling integration with existing hospital imaging systems while automating routine interpretation tasks and reducing clinician time-to-diagnosis.

Luna Aesthetic (Luña Medical Technology) is a US-based medical device manufacturer with Spanish heritage specializing in innovative aesthetic laser and imaging solutions for med spas and clinical professionals. The company develops multi-modality diode laser workstations (808nm wavelength) capable of treating diverse skin types and tones for hair removal, skin rejuvenation, vascular treatment, and tattoo removal. Luna Aesthetic also offers the Luna X, an AI-powered facial skin analysis platform providing high-quality imaging and clinical assessment. The company emphasizes clinical rigor, automatic parameter adjustment based on skin type, and comprehensive customer support. Luna Aesthetic holds FDA and CE certifications and operates with worldwide service capabilities, complemented by hands-on, expert-led training programs for practitioners.

Clear Labs is a genomics testing company specializing in fully automated next-generation sequencing (NGS) platforms for clinical diagnostics, food safety, and research applications. The company delivers end-to-end solutions integrating robotic automation, genomic sequencing, and bioinformatics software for pathogen detection, infectious disease surveillance, and oncology research. Clear Labs offers clinical diagnostic solutions for rapid bacterial and fungal identification from sterile specimens, whole genome sequencing for microbial surveillance, and food safety testing platforms (Clear Safety™) for Salmonella and Listeria detection and serotyping. Research-use-only platforms include Clear Dx® for oncology NGS workflows and Clear Ix™ for infectious disease sequencing. The company serves clinical laboratories, food safety operations, and research institutions, providing actionable molecular insights to reduce foodborne illness outbreaks and accelerate infectious disease and cancer genomics research.

Altamont Software provides enterprise medical imaging connectivity and workflow management solutions that integrate non-DICOM imaging data with EHR, PACS, and VNA systems across healthcare organizations. The company offers a unified platform with IHE-compliant, zero-footprint applications for DICOM SR integration, document scanning and capture, medical video capture, and DICOM media creation. Key solutions include Passport SR (automated DICOM Structured Report data population into radiology reports), CaptureWare (paper document, CD, photo, and form integration), CaptureWare Video (medical scope video capture and integration), Outbox (enterprise DICOM CD/DVD creation and management), and eForms (electronic clinical documentation). The platform emphasizes centralized administration, HIPAA compliance, access control, data encryption, and LDAP integration to streamline radiologist workflows, improve data accuracy, and reduce manual documentation burden across large healthcare systems.

CellTivity Scientific is a medical technology company specializing in live-cell imaging platforms for real-time assessment of cellular behavior, morphology, and metabolic activity. The flagship Van Gogh Microscopy System utilizes proprietary Dynamic Cell Imaging (DCI) technology to provide non-invasive visualization of metabolic activity and tissue adequacy during biopsies. The system enables proceduralists to identify cell types—including cancer cells, immune cells, and granuloma—and assess biopsy sample quality in real time, improving diagnostic yield and reducing biopsy inadequacy. Applications span interventional pulmonology, thoracic procedures, bronchoscopy, and general tissue sampling across oncology specialties. The company offers CE-registered devices with deployment, training, and pathology integration support to hospitals and clinics, targeting enhanced point-of-care diagnostics and streamlined collaboration with pathology departments.

SafeBeat Rx is a digital health company specializing in AI-powered remote monitoring and therapeutic management for cardiac conditions, particularly atrial fibrillation (AFib) and heart failure. The SafeBeat Platform is a mobile-accessible system featuring proprietary ECG analysis algorithms and AI-driven clinical decision support tools designed for clinicians. The platform integrates data from FDA-cleared cardiac monitoring devices (mobile ECG, mobile cardiac telemetry, and implantable cardiac monitors) to deliver near real-time insights while minimizing alert fatigue. SafeBeat's explainable AI technology goes beyond diagnostics to guide therapeutic interventions, including personalized medication dosing and treatment recommendations. The company, founded in 2020 and led by cardiologist Dr. Rachita Navara and bioengineer Dr. Kunj Patel, focuses on improving healthcare access, reducing costs, and enhancing clinical workflows for cardiac care in hospital and remote monitoring settings.

DOSIsoft is a global medical software company specializing in dosimetry solutions for Radiation Oncology and Nuclear Medicine. Founded in 2002 as a spin-off from Institut Gustave Roussy and Institut Curie in Paris, the company develops advanced treatment planning, quality assurance, and personalized dosimetry software. Its core offerings include ISOgray® (treatment planning), ThinkQA Suite (patient-specific QA and secondary dose checking), EPIbeam (phantomless pretreatment verification), EPIgray® (in vivo dosimetry), and PLANET® (multi-radionuclide platform for molecular radiotherapy and imaging diagnostics). The solutions incorporate AI-based quantitative imaging, radiomics, and machine learning capabilities. DOSIsoft's software is deployed in over 600 hospitals across 60 countries and is ISO 9001 and ISO 13485 certified. The company addresses critical clinical workflows in adaptive radiotherapy, IMRT/VMAT verification, molecular radiotherapy dosimetry (90Y-SIRT, 177Lu), and theranostics applications.

Intelerad Medical Systems is a leading provider of cloud-based medical imaging software and enterprise workflow solutions established in 1999. The company specializes in scalable PACS (Picture Archiving and Communication Systems), diagnostic imaging viewing, AI-enhanced reporting, secure image sharing, and clinical workflow orchestration. Intelerad's platform manages over 50 billion medical images and supports more than 300,000 clinicians conducting 140+ million exams annually. Key product offerings include IntelePACS® for image archival and management, InteleViewer™ for zero-footprint diagnostic viewing, InteleShare for secure patient imaging exchange, InteleOrchestrator for AI-powered clinical worklist prioritization, and InteleGence AI tools for precision diagnostics assistance. The company serves nearly 2,500 healthcare organizations globally—including radiology groups, hospitals, cardiology practices, and outpatient imaging centers—with operations across six countries and over 900 employees.

ZEISS Group is a leading German multinational optical and optoelectronics company founded in 1846, headquartered in Oberkochen with approximately 30 production and 25 development sites across nearly 50 countries. The company specializes in precision optics, optical systems, and advanced medical technologies. In medical technology, ZEISS manufactures diagnostic imaging systems, surgical microscopes, and ophthalmic devices including diagnostic systems and intraocular lenses through Carl Zeiss Meditec AG. Its research microscopy division develops optical, electron, and ion microscopes for life sciences and materials research. ZEISS also supplies semiconductor manufacturing equipment and industrial metrology solutions. The company demonstrates expertise in AI-enhanced imaging, digital health solutions, and innovation across healthcare, industrial, and research sectors. With consolidated earnings of approximately €2 billion annually, ZEISS maintains a commitment to precision engineering and technological advancement across multiple high-value markets.